Testing effectiveness (Phase 2)Ended earlyNCT05360238
What this trial is testing
Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL
Who this might be right for
Follicular B-cell Non-Hodgkin's LymphomaMantle Cell Lymphoma RecurrentMantle Cell Lymphoma Refractory+5 more
Mustang Bio 20